The final determination also adds coverage for FDA-approved tests in stage III patients, and for repeat testing if patients receive a new primary diagnosis.

The decision, which the company said was made for business and financial reasons, raises questions about the viability of such tests in the face of reimbursement uncertainly.


Using an atypical assembly strategy, researchers tackled the genome of Solenodon paradoxus, an endangered venomous, shrew-like animal from Hispaniola.

The suit alleges that Natera's Panorama test infringes US Patent No. 9,493,831 patent, which covers sequencing library preparation methods applied to maternal blood samples.

Thermo Fisher said that IntegenX complements and enhances its existing human identification product portfolio.

An impetus for the review included the fact that companies are advertising and promoting liquid biopsy in areas where the technology has not yet proven its clinical utility.

As genomics increasingly becomes a part of healthcare, more diverse datasets will be needed to avoid biases in algorithms used to analyze data and make diagnoses.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.

Sponsored by

Machine learning is a field of computer science that gives computers the ability to learn without being explicitly programmed. This webinar explores the basics of machine learning, focusing on the industry standard CRISP-DM (Cross Industry Standard Process for Data Mining), and how to apply the method to a molecular diagnostic technique such as PCR. The webinar also discusses the implications of current PCR analysis software and the lack of artificial intelligence. Lastly - a novel and improved way of analyzing PCR results is introduced.

This application note demonstrates that:

• The new Applied Biosystems SeqStudio Genetic Analyzer generates high-quality data from multiplex ligation–dependent probe amplification (MLPA) assays developed by MRC-Holland.

• The SeqStudio Genetic Analyzer provides fast and efficient results; each run cycle accommodates 4 MLPA reaction samples and can be completed within 45 min.